Shilpa Medicare Share Price

₹ 924.55

-₹31.05 (-3.25%)

Last updated 02 Nov, 2026, 15:58 IST

NSE: SHILPAMED

Shilpa Medicare Share Price Today

As of 3 Nov 2026, Shilpa Medicare share price is ₹924.55. The stock opened at ₹957.00, compared to its previous close of ₹955.60. During today's trading session, Shilpa Medicare share price moved in the range of ₹916.25 to ₹961.00, with an average price of ₹938.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹259.50 and a high of ₹1,095.00. On the performance front, Shilpa Medicare share price has increased by 127.36% over the last six months and is up 162.02% on a year-on-year basis.

₹916.25

3.25% down today

₹961.00

1D LOW

1D HIGH

Shilpa Medicare Stock Insights

Latest Earning

Op Profit TrendUp by 141.40% YoY

Latest Earning

Net Profit TrendUp by 210.81% YoY

Latest Earning

Revenue TrendUp by 6.90% QoQ

Stock Performance

OutperformingBeat Nifty by 61.8 % in last 3 month

Shareholding Pattern

DIIDII increased stake by 5.71%

Shareholding Pattern

FIIFII increased stake by 6.38%

Shilpa Medicare Stock Insights

Latest Earning

Op Profit TrendUp by 141.40% YoY

Latest Earning

Net Profit TrendUp by 210.81% YoY

Latest Earning

Revenue TrendUp by 6.90% QoQ

Stock Performance

OutperformingBeat Nifty by 61.8 % in last 3 month

Shareholding Pattern

DIIDII increased stake by 5.71%

Shareholding Pattern

FIIFII increased stake by 6.38%

Shilpa Medicare stock performance
Open	₹957.00
High	₹961.00
Low	₹916.25
Prev. close	₹955.60

Shilpa Medicare trading activity
Volume	5,55,053
Average traded price	₹934.62
Last traded time	03:58:28 02 Nov
Last traded quantity	2

₹764.50₹1,146.70

Circuit Low

Circuit High

₹259.50₹1,095.00

52-Week Low

52-Week High

Circuit

₹764.50

₹1,146.70

52-week

₹259.50

₹1,095.00

Mkt Cap Cr

18,671.22

P/E

62.81

P/B

7.21

ROA

8.02%

ROE

9.39%

ROCE

10.73%

Quick Ratio

0.88

EV/EBITDA

36.99

Mkt Cap Cr

18,671.22

P/E

62.81

P/B

7.21

ROA

8.02%

ROE

9.39%

ROCE

10.73%

Quick Ratio

0.88

EV/EBITDA

36.99

Based on fundamentals, this stock's

Performance

Very Poor

Shilpa Medicare has not beaten FD return of 7%

Valuation

Overvalued

Shilpa Medicare appears overvalued compared to its peers

Earnings

Good

Shilpa Medicare revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Shilpa Medicare Company Background

ISIN

INE790G01031

Sector Market Cap

₹ 18,671.22 Cr

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.

Shilpa Medicare Financial Highlights

Revenue: Shilpa Medicare reported revenue of ₹1,548.71 crore in FY26 vs ₹1,309.76 crore in FY25. It showed an increase of 18.24% on a yearly basis.
Operating Profit: Shilpa Medicare reported an operating profit of ₹295.31 crore in FY26 vs ₹122.33 crore in FY25. It showed an increase of 141.40% on a year-on-year basis.
Net Profit: Shilpa Medicare reported a net profit of ₹243.33 crore in FY26 vs ₹78.29 crore in FY25. It showed an increase of 210.81% on a yearly basis.

Shilpa Medicare Quarterly Result Highlights

Shilpa Medicare reported revenue of ₹468.91 crore in Jun 2026, compared with ₹438.66 crore in Mar 2026, representing an increase of 6.90% on a quarter-on-quarter (QoQ) basis.
Shilpa Medicare reported an operating profit of ₹98.06 crore in Jun 2026, compared with ₹120.44 crore in Mar 2026, representing a decrease of 18.58% on a quarter-on-quarter (QoQ) basis.
Shilpa Medicare reported a profit of ₹100.88 crore in Jun 2026, compared with ₹107.79 crore in Mar 2026, reflecting a decrease of 6.41% on a QoQ basis.
The earnings per share (EPS) of Shilpa Medicare stood at ₹12.44 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

40.13%

FII

12.11%

Other DII

4.06%

Retail and other

39.49%

Mutual funds

4.20%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	10.97%
Mar 2026	11.08%
Jun 2026	11.38%
Sep 2026	12.11%

Shilpa Medicare Investment Returns

1 day

-3.25%

1 week

+2.64%

1 month

-13.11%

1 year

+162.02%

3 years

+428.92%

5 years

+208.49%

Shilpa Medicare Share Price History

Shilpa Medicare share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹957.00 / ₹924.55	-3.25%
30 Oct 26	₹955.90 / ₹955.60	+2.14%
29 Oct 26	₹932.00 / ₹935.60	+0.39%
28 Oct 26	₹909.00 / ₹932.00	+3.02%
27 Oct 26	₹912.60 / ₹904.70	+0.43%
26 Oct 26	₹880.00 / ₹900.80	+4.22%
23 Oct 26	₹860.80 / ₹864.30	+0.41%
22 Oct 26	₹826.30 / ₹860.80	+1.85%
21 Oct 26	₹855.10 / ₹845.20	-3.54%
19 Oct 26	₹890.00 / ₹876.20	-6.55%

Shilpa Medicare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹1,538.87	₹1,286.43	₹1,151.60	₹1,050.11
Other Income	₹9.84	₹23.33	₹8.17	₹17.40
Total Revenue	₹1,548.71	₹1,309.76	₹1,159.77	₹1,067.51
Total Expenses	₹1,282.68	₹1,155.58	₹1,106.79	₹1,101.98
Profit Before Tax	₹295.31	₹122.33	₹54.34	-₹38.28
Tax	₹51.98	₹44.04	₹22.39	-₹7.31
Profit After Tax	₹243.33	₹78.29	₹31.96	-₹30.97
EPS - Basic	₹12.44	₹4.02	₹3.67	-₹3.75
EPS - Diluted	₹12.44	₹4.02	₹3.67	-₹3.75

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹295.31	₹122.33	₹54.34	-₹38.28
Income before WC changes	₹437.76	₹317.38	₹275.78	₹109.53
Change in Assets	-₹98.70	-₹122.72	-₹125.72	₹107.29
Change in Liabilities	₹63.53	-₹15.37	₹27.80	-₹4.52
Change in WC	-₹35.17	-₹138.09	-₹97.92	₹102.77
Cash flow from Operations	₹342.18	₹132.27	₹136.67	₹179.92
Cash flow from Investing	-₹325.92	-₹199.13	-₹166.58	-₹232.61
Cash flow from Financing	₹13.62	₹62.65	₹46.78	₹45.80
Total Cash Flow	₹29.88	-₹4.21	₹16.86	-₹6.89
Cash (Start of the year)	₹28.57	₹31.76	₹19.07	₹25.62
Cash (End of the year)	₹45.18	₹28.57	₹31.76	₹19.07

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹2,595.84	₹2,326.17	₹2,216.38	₹2,134.37
Current Assets	₹1,109.77	₹984.51	₹876.83	₹769.55
Total Assets	₹3,705.61	₹3,310.68	₹3,093.20	₹2,903.93
Current Liabilities	₹848.06	₹674.19	₹693.35	₹784.45
Net Current Asset	₹261.71	₹310.32	₹183.48	-₹14.89
Non-Current Liabilities	₹266.35	₹272.75	₹599.90	₹345.12
Equity Capital	₹2,591.20	₹2,363.74	₹1,799.96	₹1,774.36
Total Equity & Liabilities	₹3,705.61	₹3,310.68	₹3,093.20	₹2,903.93

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹597.03	₹477.40	₹309.79	₹247.70
Other Income	₹38.15	₹69.67	₹89.12	₹68.64
Total Revenue	₹635.18	₹547.07	₹398.90	₹316.35
Total Expenses	₹506.47	₹396.00	₹350.36	₹359.08
Profit Before Tax	₹148.13	₹105.33	₹38.09	-₹58.28
Tax	₹15.15	₹37.43	₹11.15	-₹8.79
Profit After Tax	₹132.98	₹67.90	₹26.94	-₹49.48
EPS - Basic	₹6.80	₹3.48	₹3.10	₹6.59
EPS - Diluted	₹6.80	₹3.48	₹3.10	₹6.59

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹148.13	₹105.33	₹38.09	₹12.68
Income before WC changes	₹135.66	₹111.13	₹55.22	-₹22.88
Change in Assets	-₹69.68	-₹148.42	-₹64.71	₹21.21
Change in Liabilities	₹14.62	₹35.61	₹25.99	₹12.16
Change in WC	-₹55.06	-₹112.81	-₹38.72	₹33.37
Cash flow from Operations	₹60.00	-₹19.05	₹9.55	₹2.08
Cash flow from Investing	-₹67.16	-₹433.25	₹155.82	-₹94.83
Cash flow from Financing	₹13.76	₹450.09	-₹163.07	₹87.68
Total Cash Flow	₹6.60	-₹2.21	₹2.30	-₹5.07
Cash (Start of the year)	₹4.76	₹4.49	₹2.49	₹7.42
Cash (End of the year)	₹10.88	₹4.50	₹4.46	₹2.35

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹2,502.29	₹2,483.12	₹2,041.66	₹1,882.41
Current Assets	₹526.26	₹455.18	₹376.97	₹636.25
Total Assets	₹3,028.55	₹2,938.30	₹2,418.62	₹2,518.66
Current Liabilities	₹276.43	₹226.24	₹212.64	₹242.71
Net Current Asset	₹249.83	₹228.94	₹164.33	₹393.54
Non-Current Liabilities	₹38.74	₹65.12	₹63.27	₹158.37
Equity Capital	₹2,713.38	₹2,646.94	₹2,142.72	₹2,117.58
Total Equity & Liabilities	₹3,028.55	₹2,938.30	₹2,418.62	₹2,518.66